Telehealth & Digital Health

Belmont Medical's acquisition of Arcos fuses life-saving devices with smart software, promising a new era of data-driven care for trauma and burn patients.

A new report reveals AI overwhelmingly trusts academic hospitals, leaving major chains behind. What does this mean for patient choice and the future of healthcare?

A Dutch medtech firm is advancing a pivotal study for its VCFix® system, a device that aims to reconstruct vertebrae rather than just fill them.

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.

A key update to a revolutionary cancer therapy reduces post-treatment restrictions, signaling a new era of patient-centric care and system efficiency in Canada.

Humana secures a massive Illinois Medicaid contract, expanding its reach statewide. This strategic move signals a major shift towards whole-person care.

With a history of beating expectations and a flurry of strategic moves, Quest Diagnostics' July 23rd earnings report is a key vital sign for the entire diagnostics sector.

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.

Heart + Paw is ditching one-size-fits-all pet care, betting on vet-guided personalization. Is this tech-driven approach the future of the industry?

As giants rule the obesity market, small-cap MetaVia pitches a novel dual-agonist and a first-in-class MASH drug. Can its science win the day?

A landmark grant and trial expansion signal a pivotal shift in Parkinson's research, blending genetic targeting, global collaboration, and digital health.

New research reveals that custom 3D braces can actively correct spinal curves, not just prevent them from worsening. This paradigm shift in non-surgical care offers new hope.

21 doctors from one practice in a "Top Doctors" Hall of Fame is a headline. But what does it reveal about building trust and innovation in cancer care?

New data on ersodetug reveals a calculated strategy to conquer hyperinsulinism, balancing patient hope with the harsh realities of the biotech market.

With $1.25M in new funding, Avricore Health isn't just raising capital; it's accelerating a strategic pivot to the lucrative UK market for its HealthTab platform.

FiberSense AG’s new 28-day CGM sensor just won European approval, challenging market leaders. But the real growth signal is its plan to move beyond glucose.

A Swedish pharma company's trial is progressing faster than expected, but the real story is the potential paradigm shift for millions suffering from a neglected disease.

A new NIH contract for Tryfacta signals more than a business win; it highlights how AI-driven staffing is becoming critical to national healthcare infrastructure.

A new AU$481M deal with Everest Medicines brings a promising FSGS drug closer to 1M Asian patients, part of a larger, de-risked global strategy.

With 33% growth dwarfing industry norms, NNB Nutrition's integrated model and fermentation tech aren't just winning—they're rewriting the rules for wellness.